Current Indications definition

Current Indications means those Indications for which ALLERGAN or any of its Affiliates, as of the Effective Date, has received Regulatory Approval in the Territory to use Product for the treatment, prevention or palliation of such Indications, which Indications include blepharospasm (benign essential blepharospasm and essential blepharospasm), hemifacial spasm, and cervical dystonia (spasmodic torticollis).
Sample 1
Current Indications means cervical dystonia, migraine (chronic and episodic) and gastroparesis.” ​
Sample 1
Current Indications means (a) those therapeutic Indications for which ALLERGAN or any of its Affiliates, as of the Effective Date, had received Regulatory Approval in the Territory to use Product for the treatment, prevention or palliation of such Indications, which Indications include blepharospasm (benign essential blepharospasm and essential blepharospasm), hemifacial spasm, and cervical dystonia (spasmodic torticollis), and (b) those therapeutic Indications for which GSK and its Affiliates, as of the First Amendment Date, have submitted Regulatory Approval Applications or have received Regulatory Approval in the Territory to use Product for the treatment, prevention or palliation of such Indications, specifically juvenile cerebral palsy and upper and lower limb spasticity For clarity, “Current Indications” does not include any Cosmetic Indications within the Regulatory Approval Applications and Regulatory Approvals for BOTOX Vista® Injection. 3.5 Section 1.27 is hereby amended and replaced in its entirety as follows:
Sample 1

Examples of Current Indications in a sentence

  • Current Indications for Growth Hormone Therapy for Children and Adolescents.

  • Medial Patellofemoral Ligament Reconstruction Combined With Bony Procedures for Patellar Instability: Current Indications, Outcomes, and Complications.

  • Dialectical Behavior Therapy: Current Indications and Unique Elements.

  • Tdap Vaccine: Current Indications for Adoles- cent and Adult Patients in the United States by Jeffrey T.

  • Opthalmic Applications of Preserved Human Amniotic Membrane: A Review of Current Indications.

  • Lenabasum Market Opportunity for Current Indications Being Developed Autoimmune DisordersSystemic Sclerosis Systemic sclerosis is a chronic, systemic autoimmune disease characterized by activation of innate and adaptive immune systems, an obliterative, proliferative vasculopathy of small blood vessels, and fibrosis of the skin and multiple internal organs.

  • It was recognized that the financing problem requires further detailed consideration, but that on the other hand certain activities must continue into the new fiscal year and CIA has no funds budgeted to cover them.

  • Figure: Mode of Action of various Penicillins Current Indications of AmoxicillinAccording to its current label, amoxicillin is indicated in the treatment of infections due to susceptible non-beta- lactamase-producing strains of the designated microorganisms in the following conditions: Infections of the ear, nose, and throat: due to Streptococcus species (alpha-beta-hemolytic strains only), S.

  • Human Papillomavirus Vaccination : Current Indications and Future Directions.

  • Attend one of the following workshops.Moderator: Workshop I: Current Indications and UsesWanda Miller-Hance, MD of TEE for Congenital Heart SurgeryModerator: Workshop II: Pediatric Track CardiovascularDean B.


More Definitions of Current Indications

Current Indications means (a) those therapeutic Indications for which ALLERGAN or any of its Affiliates, as of the Effective Date, had received Regulatory Approval in the Territory to use Product for the treatment, prevention or palliation of such Indications, which Indications include blepharospasm (benign essential blepharospasm and essential blepharospasm), facial spasm, and associated focal dystonias, and (b) those therapeutic Indications for which GSK and its Affiliates, as of the First Amendment Date, have received Regulatory Approval in the Territory to use Product for the treatment, prevention or palliation of such Indications, specifically blepharospasm (benign essential blepharospasm and essential blepharospasm) and facial spasm. For clarity, “Current Indications” does not include glabellar lines within the Regulatory Approval Applications and Regulatory Approvals. 3.5 Section 1.24 is hereby amended and replaced in its entirety as follows:
Sample 1

Related to Current Indications

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • U.S. Territory means American Samoa, the Commonwealth of the Northern Mariana Islands, Guam, the Commonwealth of Puerto Rico, or the U.S. Virgin Islands.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Existing Product means any formulation of the same product category and form sold, supplied, manufactured, or offered for sale in California prior to the following dates, or any subsequently introduced identical formulation:

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Commercialized shall have corresponding meanings.

  • New Products means any product which is not an Enhanced Product or 2 Existing Product but which is substantially similar to an Existing Product with respect to design and function and possesses reasonable performance improvements. If Company desires to purchase an Enhanced or New Product(s) from Supplier, Company shall so notify Supplier and provide Supplier the opportunity to manufacture such Enhanced or New Product(s), subject to the following conditions and procedures.

  • Existing Products Tangible Products and intangible licensed Products that exist prior to the commencement of work under the contract. Existing Products must be identified on the Product prior to commencement of work or else will be presumed to be Custom Products.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Major Market Countries means the United States, Japan, England, Germany, France, Italy and Spain.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Combination Products means COBI Combination Products, EVG Combination Products, TDF Combination Products, TAF Combination Products and Quad Product.

  • Final Product means a reasonably homogenous cannabis product in its final packaged form created using the same standard operating procedures and the same formulation.

  • Additional Product means any Product identified as such in the Product Terms and chosen by Enrolled Affiliate under this Enrollment.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Cannabis products means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Cannabis product means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Licensed Territory means worldwide.